Protalix BioTherapeutics, Inc. Income (Loss) from Continuing Operations before Income Taxes, Domestic
Protalix BioTherapeutics, Inc. (PLX) reported Income (Loss) from Continuing Operations before Income Taxes, Domestic of -$4.58 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-18.
Financial Statements › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic · last filed 2026-03-18
- Protalix BioTherapeutics, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2025 was -$4.58M.
- Protalix BioTherapeutics, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2024 was -$4.55M.
- Protalix BioTherapeutics, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2023 was -$7.06M.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month |
|---|---|
| 2025-12-31 | -$4.58M 10-K · filed 2026-03-18 |
| 2024-12-31 | -$4.55M 10-K · filed 2026-03-18 |
| 2023-12-31 | -$7.06M 10-K · filed 2026-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |